Sam68 is a novel marker for aggressive neuroblastoma [Corrigendum]

Zhao X, Li Z, He B, et al. Onco Targets Ther. 2013;6: 1751–1760.

In the author affiliation section on the first page, the affiliations were shown incorrectly. The correct author affiliations are as follows:

Xiaohong Zhao,^1,* Zuoqing Li,^1,* Benfu He,² Juncheng Liu,¹ Suisheng Li,¹ Li Zhou,¹ Cuiling Pan,¹ Zhe Yu,³ Zhe Xu¹

¹Department of Pediatric Surgery, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People’s Republic of China; ²Oncology Department, PLA421 Hospital, Guangzhou, People’s Republic of China; ³Laura Biotech Co., Ltd., Guangzhou, Guangdong Province, People’s Republic of China

^*These authors contributed equally to this work